University of Chicago Medical Center

STAT to host fifth annual flagship STAT Summit

Retrieved on: 
Tuesday, October 10, 2023

BOSTON, Oct. 10, 2023 /PRNewswire/ -- STAT, the leading media company reporting on health, science, and medicine, is set to host its fifth annual flagship event, the 2023 STAT Summit, later this month. The hybrid event will take place on October 18-19, 2023, at the State Room in Boston, with programming beginning at 9:00 a.m. ET each day. The Summit will feature frank conversations on vital topics with C-suite industry leaders, and spirited discussions with leading academics and patient advocates on the biggest challenges across health care today.

Key Points: 
  • 2023 STAT Summit will feature leading executives from Eli Lilly, Biogen, GSK, and more, with virtual appearances from Michael J.
  • Fox, Mark Zuckerberg and Priscilla Chan
    BOSTON, Oct. 10, 2023 /PRNewswire/ -- STAT , the leading media company reporting on health, science, and medicine, is set to host its fifth annual flagship event, the 2023 STAT Summit , later this month.
  • The 2023 STAT Summit is presented by St. Jude Children's Research Hospital, and will feature a discussion with James R. Downing, M.D., St. Jude Children's Research Hospital president and CEO.
  • Top executives, key scientists, economists and health outcomes researchers will take the Summit stage to explore solutions together.

Ontogen Medtech Secures Illinois $50k SBIR Matching Grant to Advance Partnership with Flow Medical on Groundbreaking Pulmonary Embolism Catheter Device

Retrieved on: 
Thursday, October 5, 2023

The SBIR Phase I grant matching program was announced in 2022 by Governor JB Pritzker for companies within the State of Illinois.

Key Points: 
  • The SBIR Phase I grant matching program was announced in 2022 by Governor JB Pritzker for companies within the State of Illinois.
  • "We are deeply honored to have been selected as recipients of the SBIR matching grant from the state of Illinois," said Tyler Panian, Principal and Co-Founder of Ontogen Medtech.
  • "This grant not only reaffirms our dedication to advancing medical technologies within the state but also recognizes the significance of our collaboration with Flow Medical.
  • "We are thrilled to continue our partnership with Ontogen Medtech and appreciate the support from the State of Illinois to advance our pursuit of the catheter device's potential in revolutionizing pulmonary embolism treatment," said Jennifer Fried, CEO at Flow Medical.

Applied UV Achieves Industry Milestone: Receives First Order for Patented Disinfecting Mirrors. The Units are for Installation at a Mt. Sinai Hospital in New York

Retrieved on: 
Wednesday, August 9, 2023

NEW YORK, NY, Aug. 09, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Applied UV, Inc. (NASDAQ: AUVI), a pioneering force in Smart Buildings Technologies, is pleased to announce a significant accomplishment through its Sterilumen subsidiary: the Company's first purchase order for its disinfecting mirrors has recently been received.  This order is for the renowned Mt. Sinai Hospital in New York. This significant milestone represents  the successful culmination of three years of research, investment, and intellectual property (IP) development by Applied UV. Our patented UV disinfecting mirrors focus on typical sinks and adjacent areas.

Key Points: 
  • This significant milestone represents  the successful culmination of three years of research, investment, and intellectual property (IP) development by Applied UV.
  • Our patented UV disinfecting mirrors focus on typical sinks and adjacent areas.
  • Our various hospital partnerships underscore the trust and credibility we have built in the market," said Max Munn, CEO of Applied UV.
  • Prominent names like University of Chicago Medical, Mass General, and Mercy Children’s Hospital are among Applied UV's clientele.

DoseMe Expands Leadership Team with Appointments of Paul Edwards to CEO, John Hardesky to CCO and Sharmeen Roy to Chief Strategy & Science Officer

Retrieved on: 
Wednesday, July 12, 2023

DoseMe , a leading provider of precision dosing software for therapeutic drug monitoring and creators of DoseMeRx and DoseMe Analytics, today announced the appointments of Paul Edwards to Chief Executive Officer, John Hardesky to the role of Chief Commercial Officer and Dr. Sharmeen Roy , PharmD, BCPS, to Chief Strategy and Science Officer.

Key Points: 
  • DoseMe , a leading provider of precision dosing software for therapeutic drug monitoring and creators of DoseMeRx and DoseMe Analytics, today announced the appointments of Paul Edwards to Chief Executive Officer, John Hardesky to the role of Chief Commercial Officer and Dr. Sharmeen Roy , PharmD, BCPS, to Chief Strategy and Science Officer.
  • This expansion of the senior leadership team will enable DoseMe to continue to evolve its precision dosing capabilities and ensure it is supporting hospitals and care teams to individualize patient treatment results.
  • Paul Edwards, CEO - Previously Paul held senior executive roles with Merck and GSK, as well as start-ups including ILUM Health Solutions, Infectious Disease Connect, and TrackMy Solutions.
  • John Hardesky, CCO - An accomplished senior leader with over 20 years of commercial experience focused on the global clinical market.

Imperative Care Announces Positive New Data Demonstrating Benefits of Zoom RDL, the First Stroke-Specific Radial Access Platform for Mechanical Thrombectomy

Retrieved on: 
Thursday, June 8, 2023

Zoom RDL is the company’s latest innovation and the first radial access platform developed specifically for ischemic stroke treatment.

Key Points: 
  • Zoom RDL is the company’s latest innovation and the first radial access platform developed specifically for ischemic stroke treatment.
  • Zoom RDL provides neurointerventionalists with an alternative option to femoral access to treat their stroke patients, helping to enable the best possible outcome based on an individual patient’s anatomy.
  • “Adoption of transradial access for neurointerventional procedures is at an early phase with the need for additional data supporting its use.
  • “Our patient-first portfolio includes two options for intracranial access, Zoom 88 for femoral access and Zoom RDL for radial access, empowering clinicians to choose the best option for their patients based on their anatomy.

The Larry H. Miller Company Elects Paul J. Carbone to its Board of Directors

Retrieved on: 
Tuesday, May 30, 2023

SANDY, Utah, May 30, 2023 /PRNewswire/ -- The Larry H. Miller Company (the LHM Company) announced the election of its newest board member, Paul J. Carbone. He is the co-founder and president of Pritzker Private Capital (PPC) and also chairs the PPC Management and Investment Committees. Carbone has been with PPC and its predecessor since 2012 and was previously president and managing partner.

Key Points: 
  • SANDY, Utah, May 30, 2023 /PRNewswire/ -- The Larry H. Miller Company (the LHM Company) announced the election of its newest board member, Paul J. Carbone.
  • "We are pleased to welcome Paul to the board of directors for our family business," said Steve Miller, board chair of the LHM Company.
  • Haslam, a childhood friend of Larry Miller, previously worked for the Larry H. Miller Company, including as president of the Utah Jazz and Larry H. Miller Sports & Entertainment.
  • After he retired from the LHM Company, Haslam assisted Gail Miller in forming the company's board of directors in 2015.

Lighten, a Chicago-based, nationally-facing startup, has launched Your Memorial, Your Way™

Retrieved on: 
Monday, April 3, 2023

Many people today are interested in including this type of plan as part of their estate planning decisions.

Key Points: 
  • Many people today are interested in including this type of plan as part of their estate planning decisions.
  • There are major benefits to pre-planning a memorial:
    Allows individuals to have input into how their legacy is defined and how their life is remembered.
  • Offers guidance to loved ones who, when faced with a death, are often overwhelmed by the array of decisions to be made.
  • "Lighten empowers families to plan uplifting memorials that celebrate their loved ones' authentic personal, cultural, and spiritual identities.

NKGen Biotech Announces Formation of Scientific Advisory Board to Drive its Pipeline Strategy for Natural Killer Cell Therapies Targeting Neurodegenerative Diseases

Retrieved on: 
Wednesday, March 8, 2023

The newly formed SAB will provide strategic, scientific, and clinical guidance as the Company progresses its pipeline of innovative natural killer cell therapies targeting neurodegenerative diseases such as Alzheimer’s and Parkinson’s disease.

Key Points: 
  • The newly formed SAB will provide strategic, scientific, and clinical guidance as the Company progresses its pipeline of innovative natural killer cell therapies targeting neurodegenerative diseases such as Alzheimer’s and Parkinson’s disease.
  • “We are honored to welcome such esteemed experts in the field of neurological disease to our Scientific Advisory Board,” commented Paul Y.
  • “Each brings their own respective scientific and clinical expertise in key areas including Alzheimer’s, Parkinson’s, Multiple Sclerosis, and neuroinflammation.
  • Dr. Guo is a renowned investigator in neurological disorders, with an emphasis on neurodegenerative diseases including Alzheimer’s and Parkinson’s disease.

Seres Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Updates

Retrieved on: 
Tuesday, March 7, 2023

Seres Therapeutics, Inc. (Nasdaq: MCRB), a leading microbiome therapeutics company, today reported fourth quarter and full year 2022 financial results and provided business updates.

Key Points: 
  • Seres Therapeutics, Inc. (Nasdaq: MCRB), a leading microbiome therapeutics company, today reported fourth quarter and full year 2022 financial results and provided business updates.
  • In February 2023, Seres announced the publication of Phase 3 ECOSPOR IV trial results in JAMA Network Open and results were also shared at the IDWeek and American College of Gastroenterology (ACG) 2022 Annual Meetings.
  • Research and development expenses for the fourth quarter of 2022 were $46.2 million, compared with $36.8 million for the same period in 2021.
  • General and administrative expenses for the fourth quarter of 2022 were $22.4 million, compared with $20.5 million for the same period in 2021.

Specialized Education Services, Inc. Names Dawn Thomas President

Retrieved on: 
Monday, November 7, 2022

PHILADELPHIA, Nov. 07, 2022 (GLOBE NEWSWIRE) -- Specialized Education Services, Inc. (SESI), a premier provider of education services for K-12 students who require additional educational and positive behavioral supports to overcome challenges that impede success in a traditional school setting, today announced the hiring of Dawn Thomas as president.

Key Points: 
  • PHILADELPHIA, Nov. 07, 2022 (GLOBE NEWSWIRE) -- Specialized Education Services, Inc. (SESI), a premier provider of education services for K-12 students who require additional educational and positive behavioral supports to overcome challenges that impede success in a traditional school setting, today announced the hiring of Dawn Thomas as president.
  • Thomas will lead the growth and development of SESIs special education and alternative education programs, as well as identify, attract and cultivate talent.
  • The work SESI does is life-changing for so many students who require additional support to achieve success, said Thomas.
  • Thomas, whose mother is a retired special education teacher, grew up in a household where schooling was a top priority.